Aleshia buys IDIX 24.5: Merck - Current Valuation Is Based On Future Pipeline, Amidst Poor Current Earnings Quality
This sale could allow the company to completely reduce its net debt position, but a sizable part of these anticipated proceeds have already been used to acquire Idenix Pharmaceuticals (IDIX ... time when Gilead's Sciences (NASDAQ:GILD) Sovaldi is a ... ...
28 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home